Click here to view the printer friendly version of this press release
"We have been very impressed by the MRX technology of Manhattan Scientifics and believe that this technology has high potential to transform the field of cancer diagnostics. We look forward to working with them to generate shareholder value in the months ahead."
NEW YORK--Manhattan Scientifics, Inc. today announced the engagement of Torreya Partners and its professional services sister company, Torreya Insights.
Torreya Partners is a leading financial advisory firm that has facilitated over 100 M&A, licensing and asset sale transactions in the life sciences industry. Tim Opler of Torreya Partners indicated: "We have been very impressed by the MRX technology of Manhattan Scientifics and believe that this technology has high potential to transform the field of cancer diagnostics. We look forward to working with them to generate shareholder value in the months ahead."
Manhattan Scientifics Inc. (www.mhtx.com) is focused on commercialization of disruptive technologies in the nano medicine space.
This press release contains forward-looking statements, which are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. Management at Manhattan Scientifics believes that purchase of its shares should be considered to be at the high end of the risk spectrum. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements.